Discovery may help boost peptide design

  07 May 2021

Peptides – short strings of amino acids – play a vital role in health and industry, with a huge range of medical uses, including in antibiotics, anti-inflammatory and anti-cancer drugs. They are also used in the cosmetics industry and for enhancing athletic performance.

Altering the structure of natural peptides to produce improved compounds is therefore of great interest to scientists and industry. But how the machineries that produce these peptides work still isn’t clearly understood.

EMBL Australia and Monash Biomedicine Discovery Institute (BDI) group leader Associate Professor Max Cryle has revealed a key aspect of peptide machineries in a paper published in Nature Communications this week.

Further reading: EMBL Australia
Author(s): EMBL Australia
Smart Innovations  
Back

OUR UNDERWRITERS

Unrestricted financial support by:

LifeArc

Antimicrobial Resistance Fighter Coalition

Bangalore Bioinnovation Centre

INTERNATIONAL FEDERATION PHARMACEUTICAL MANUFACTURERS & ASSOCIATIONS





AMR NEWS

Every two weeks in your inbox

Because there should be one newsletter that brings together all One Health news related to antimicrobial resistance: AMR NEWS!

Subscribe

What is going on with AMR?
Stay tuned with remarkable global AMR news and developments!

Keep me informed